Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

NCT00217425 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bevacizumab
DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: prednisone
DRUG: vincristine

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]